Carmelo Cuffari

Associate Professor

1993 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Carmelo Cuffari is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Crohn Disease Medicine & Life Sciences
Inflammatory Bowel Diseases Medicine & Life Sciences
6-Mercaptopurine Medicine & Life Sciences
Pediatrics Medicine & Life Sciences
Ulcerative Colitis Medicine & Life Sciences
Azathioprine Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Thioguanine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1993 2019

Open Access
Inflammatory Bowel Diseases
Anemia
Pediatrics
Ulcerative Colitis
Crohn Disease

Contrast-enhanced ultrasound and shear wave elastography evaluation of Crohn's disease activity in three adolescent patients

Thimm, M. A., Cuffari, C., Garcia, A., Sidhu, S. & Hwang, M., May 1 2019, In : Pediatric Gastroenterology, Hepatology and Nutrition. 22, 3, p. 282-290 9 p.

Research output: Contribution to journalArticle

Open Access
Elasticity Imaging Techniques
Crohn Disease
Inflammation
Fibrosis
Pathologic Constriction
Testosterone Congeners
Oxymetholone
Androgens
Blood Vessels
Esophageal Stenosis

Diagnosis of congenital and acquired focal lesions in the neck, abdomen, and pelvis with contrast-enhanced ultrasound: a pictorial essay

Thimm, M. A., Rhee, D., Takemoto, C. M., Karnsakul, W. W., Cuffari, C., Guerrerio, A. L., Garcia, A., Gearhart, J. P., Huisman, T. A. G. M. & Hwang, M., Jul 3 2018, (Accepted/In press) In : European Journal of Pediatrics. p. 1-12 12 p.

Research output: Contribution to journalArticle

Pelvis
Abdomen
Neck
Pediatrics
Population

6-Mercaptopurine therapy

Cuffari, C., Jun 6 2017, Pediatric Inflammatory Bowel Disease: Third Edition. Springer International Publishing, p. 375 1 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

6-Mercaptopurine
Therapeutics